Proteomics in nasopharyngeal carcinoma

Cellular and Molecular Life Sciences

Volumn 65, Issue 7-8, 2008, Pages 1007-1012

  Li, F ^a,b   Guan, Y ^b   Chen, Z ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Biomarker; Diagnosis pattern; Nasopharyngeal carcinoma; Proteomics

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; MAC2 BINDING PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOME; UNCLASSIFIED DRUG;

HUMAN; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEOMICS; SHORT SURVEY;

HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 42449146170     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-7444-4     Document Type: Short Survey

References (50)

1. Wei, W. I. and Sham, J. S. (2005) Nasopharyngeal carcinoma. Lancet 365, 2041-2054.
2. Parkin, D. M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
3. Lo, K. W. and Huang, D. P. (2002) Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 451-462.
4. McDermott, A. L., Dutt, S. N. and Watkinson, J. C. (2001) The aetiology of nasopharyngeal carcinoma. Clin. Otolaryngol. Allied Sci. 26, 82 -92.
5. Hildesheim, A., Apple, R. J., Chen, C. J., Wang, S. S., Cheng, Y. J., Klitz, W., Mack, S. J., Chen, I. H., Hsu, M. M., Yang, C. S., Brinton, L. A., Levine, P. H. et al. (2002) Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J. Natl. Cancer Inst. 94, 1780-1789.
6. Feng, B. J., Huang, W., Shugart, Y. Y., Lee, M. K., Zhang, F., Xia, J. C., Wang, H. Y., Huang, T. B., Jian, S. W., Huang, P., Feng, Q. S., Huang, L. X. et al. (2002) Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat. Genet. 31, 395-399.
7. Xiong, W., Zeng, Z. Y., Xia, J. H., Xia, K., Shen, S. R., Li, X. L., Hu, D. X., Tan, C., Xiang, J. J., Zhou, J., Deng, H., Fan, S. Q. et al. (2004) A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 64, 1972-1974.
8. Yu, M. C., Ho, J. H., Ross, R. K. and Henderson, B. E. (1981) Nasopharyngeal carcinoma in Chinese - salted fish or inhaled smoke? Prev. Med. 10, 15 -24.
9. Chen, Z. C., Pan, S. C. and Yao, K. T. (1991) Chemical transformation of human embryonic nasopharyngeal epithelial cells in vitro. IARC Sci Publ, 434-438.
10. Chen, Z. C. (1989) [Neoplastic transformation of human embryonic/nasopharyngeal epithelial cells induced by N N′- dinitrosopiperazine (DNP) in vitro] (article in Chinese). Zhonghua Bing Li Xue Za Zhi 18, 284-286.
11. Lo, K. W., To, K. F. and Huang, D. P. (2004) Focus on nasopharyngeal carcinoma. Cancer Cell 5, 423-428.
12. Busson, P., Keryer, C., Ooka, T. and Corbex, M. (2004) EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol. 12, 356-360.
13. Niedobitek, G. (2000) Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol. Pathol. 53, 248-254.
14. Tsao, S. W., Tramoutanis, G., Dawson, C. W., Lo, A. K. and Huang, D. P. (2002) The significance of LMP1 expression in nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 473-487.
15. Patterson, S. D. (2003) Data analysis - The Achilles heel of proteomics. Nat. Biotechnol. 21, 221-222.
16. Tyers, M. and Mann, M. (2003) From genomics to proteomics. Nature 422, 193-197.
17. Yan, W., Lee, H., Deutsch, E. W., Lazaro, C. A., Tang, W., Chen, E., Fausto, N., Katze, M. G. and Aebersold, R. (2004) A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry. Mol. Cell. Proteomics 3, 1039-1041.
18. Delahunty, C. and Yates, J. R., 3rd (2005) Protein identification using 2D-LC-MS/MS. Methods 35, 248-255.
19. Nagele, E., Vollmer, M., Horth, P. and Vad, C. (2004) 2D-LC/MS techniques for the identification of proteins in highly complex mixtures. Expert Rev. Proteomics 1, 37-46.
20. Frohlich, T. and Arnold, G. J. (2006) Proteome research based on modern liquid chromatography-tandem mass spectrometry: separation, identification and quantification. J. Neural Transm. 113, 973-994.
21. Poon, T. C. (2007) Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev. Proteomics 4, 51-65.
22. Engwegen, J. Y., Gast, M. C., Schellens, J. H. and Beijnen, J. H. (2006) Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci. 27, 251-259.
23. Kondo, T. and Hirohashi, S. (2006) Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat. Protoc. 1, 2940-2956.
24. Mann, M. (2006) Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell. Biol. 7, 952-958.
25. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin, I. E. and Liotta, L. A. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981-1989.
26. Witze, E. S., Old, W. M., Resing, K. A. and Ahn, N. G. (2007) Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 4, 798-806.
27. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G. and Snyder, M. (2007) Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. USA 104, 17494-17499.
28. Li, F., Xiao, Z., Zhang, P., Li, J., Li, M., Feng, X., Guan, Y. and Chen, Z. (2007) A reference map of human nasopharyngeal squamous carcinoma proteome. Int. J. Oncol. 30, 1077-1088.
29. Li, F., Li, M., Xiao, Z., Zhang, P., Li, J. and Chen, Z. (2006) Construction of a nasopharyngeal carcinoma 2D/MS repository with Open Source XML database - Xindice. BMC Bioinformatics 7, 13.
30. Yang, H. Y., Xiao, Z. Q. and Li, F. (2004) [Establishment of 2-dE map of human low differentiation nasopharyngeal carcinoma cell line CNE-2 proteome] (article in Chinese). Zhong Nan Da Xue Xue Bao Yi Xue Ban 29, 123-128.
31. Liang, K., Chen, Z. C., Yi, H., Li, J. L., Zhang, P. F., Li, M. Y., Li, C., Feng, X. P., Peng, F. and Xiao, Z. Q. (2007) Screening of EGFR-regulated secreted proteins in human NPC cell line CNE2. Prog. Biochem. Biophys. 34, 100-106.
32. Cho, W. C. (2007) Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol. Cancer 6, 1.
33. Wu, C. C., Chien, K. Y., Tsang, N. M., Chang, K. P., Hao, S. P., Tsao, C. H., Chang, Y. S. and Yu, J. S. (2005) Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 5, 3173-3182.
34. Doustjalali, S. R., Yusof, R., Govindasamy, G. K., Bustam, A. Z., Pillay, B. and Hashim, O. H. (2006) Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J. Med. Invest. 53, 20-28.
35. Xiao, Z., Chen, Y., Yi, B. and Chen, Z. (2007) Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis. Proteomics Clin. Appl. 1, 688-698.
36. Feng, X. P., Chen, Z. C., Xiao, Z. Q., Yang, H. Y., Zhuge, Q., Zhu, G., Yang, Y. X., Li, M., Li, C., Li, M. Y., Li, F., Zhang, P. F. et al. (2005) Over expression of NM23-H1, DJ1 and TIM 1 in poor differential nasopharyngeal carcinoma tissues and CNE2 cell line. Prog. Biochem. Biophys. 32, 338-346.
37. Yan, G., Li, L., Tao, Y., Liu, S., Liu, Y., Luo, W., Wu, Y., Tang, M., Dong, Z. and Cao, Y. (2006) Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology. Proteomics 6, 1810-1821.
38. Cho, W. C., Yip, T. T., Yip, C., Yip, V., Thulasiraman, V., Ngan, R. K., Yip, T. T., Lau, W. H., Au, J. S., Law, S. C., Cheng, W. W., Ma, V. W. et al. (2004) Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin. Cancer Res. 10, 43-52.
39. Cho, W. C., Yip, T. T., Ngan, R. K., Yip, T. T., Podust, V. N., Yip, C., Yiu, H. H., Yip, V., Cheng, W. W., Ma, V. W. and Law, S. C. (2007) ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin. Chem. 53, 241-250.
40. Guo, X., Cao, S. M., Yu, J. K., Hong, M. H., Zhang, C. Q., Li, N. W., Xiang, Y. Q., Qian, C. N., Hu, X., Min, H. Q. and Zeng, Y. X. (2005) Distinct serumal proteomic patterns between ascending and descending types of loco-regionally advanced nasopharyngeal carcinoma assessed by surface enhanced laser desorption ionization and artificial neural network analyses. Chin. Med. J. 118, 1912-1917.
41. Chang, J. T., Chen, L. C., Wei, S. Y., Chen, Y. J., Wang, H. M., Liao, C. T., Chen, I. H. and Cheng, A. J. (2006) Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry - Plasma peptidomes from nasopharyngeal cancer patients for example. Clin. Biochem. 39, 1144-1151.
42. Ho, D. W., Yang, Z. F., Wong, B. Y., Kwong, D. L., Sham, J. S., Wei, W. I. and Yuen, A. P. (2006) Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma. Cancer 107, 99-107.
43. de Bont, J. M., den Boer, M. L., Kros, J. M., Passier, M. M., Reddingius, R. E., Smitt, P. A., Luider, T. M. and Pieters, R. (2007) Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis. J. Neuropathol. Exp. Neurol. 66, 505-516.
44. Koike, H., Uzawa, K., Nakashima, D., Shimada, K., Kato, Y., Higo, M., Kouzu, Y., Endo, Y., Kasamatsu, A. and Tanzawa, H. (2005) Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int. J. Oncol. 27, 59 -67.
45. Jiang, P., Gan, M., Huang, H., Shen, X., Wang, S. and Yao, K. (2005) Proteome analysis of antiproliferative mechanism of 12-O-tetradecanoylphorbol 13-acetate on cultured nasopharyngeal carcinoma CNE2 cells. J. Proteome Res. 4, 599-605.
46. Agaoglu, F. Y., Dizdar, Y., Dogan, O., Alatli, C., Ayan, I., Savci, N., Tas, S., Dalay, N. and Altun, M. (2004) P53 overexpression in nasopharyngeal carcinoma. In Vivo 18, 555-560.
47. Hu, W., Xiao, Z. Q., Chen, Z. C., Li, J. L., Zhang, P. F., Feng, X. P., Yi, H., Yu, Y. H., Tang, X. K., Liu, Q. P. and Liang, S. P. (2004) Separation and identification of p53 interacting proteins from human nasopharyngeal carcinoma cells. Prog. Biochem. Biophys. 31, 628-634.
48. Sun, Y., Yi, H., Zhang, P. F., Li, M. Y., Li, C., Li, F., Peng, F., Feng, X. P., Yang, Y. X., Yang, F., Xiao, Z. Q. and Chen, Z. C. (2007) Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett. 581, 131-139.
49. Sung, F. L., Pang, R. T., Ma, B. B., Lee, M. M., Chow, S. M., Poon, T. C. and Chan, A. T. (2006) Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma. J. Proteome Res. 5, 3260-3267.
50. Li, C. P., Huang, J. H., Chang, A. C., Hung, Y. M., Lin, C. H., Chao, Y., Lee, S. D., Whang-Peng, J. and Huang, T. S. (2004) A G-quadruplex ligand 3,3′-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells. Pharm. Res. 21, 93 -100.